10.1002/anie.201810331
Angewandte Chemie International Edition
COMMUNICATION
harnessed to prevent escape of the redox cofactor species
NADP(H) from the gel under flow conditions. To investigate this
hypothesis, microreactors were loaded with hydrogels bearing 1
mM co-entrapped NADP+ and perfused with reaction buffer
containing only glucose and NDK. Indeed, the NDK was
continuously converted for more than 30 h, indicating the
effective retainment of the entrapped cofactor inside the
hydrogel over ≥124 reactor column volumes (Figure 3f). By
decreasing the NADP-concentration to 1 µM the total turnover
number of NADPH (TTNNADPH) was greater than 14000 (Figure
3g, S11). This is more than 13-fold higher than that of a recently
reported self-sufficient heterogeneous biocatalyst, based on
bead-bound ketoreductases with electrostatically co-immobilized
NADP(H)[15]. To the best of our knowledge, the TTNNADPH
observed here is the highest value ever reported for flow
processes in devices lacking supportive membranes, thereby
clearly meeting the demands determined for economically
feasible processes.[16]
monooxygenases[21], imine reductases[22] or transaminases.[23]
Conventional approaches for cofactor retainment in flow
systems use ultra- and nanofiltration membranes or specifically
modified surfaces that retain cofactors through electrostatic
attraction or even covalent immobilization. While these
approaches have led to increased TTNNADPH values, they can
increase the complexity of production processes and costs,
24]
thereby leading to limited economic viability.[15,
Our self-
assembly approach, in contrast, is straightforward, scalable[25]
and, owing to the gel’s intrinsic material properties, can be
readily implemented in arbitrary reactor geometries. We
therefore believe that this work paves the way for the
development of novel catalytic biomaterials for applications in
continuous flow biocatalysis.
Acknowledgements
As a further demonstration of the hydrogels’ utility for
applications in continuous flow biocatalysis, hydrogel-loaded
micro reactors were used for continuous production of chiral (R)-
configured alcohols (Figure 3h). To this end, the chip was
sequentially perfused with solutions of four different methyl
ketone substrates that were converted to their respective (R)-
alcohols (5a, 7a and 9a, in Figure 3h). Each substrate
administration was conducted for 10 h and reaction products in
the outflow were analyzed by chiral HPLC. We found that all
substrates were reduced to the corresponding (R)-configured
alcohols with near quantitative conversion and stereoselectivities
of >99%. These results clearly show that the novel biocatalytic
This work was supported by the Helmholtz programme
“BioInterfaces in Technology and Medicine” and DFG project
Ni399/15-1. We thank Ishtiaq Ahmed, Jens Bauer, Anke Dech,
Leonie Hacker, Silla Hansen, Arnold Leidner, Esther Mittmann,
Hatice Mutlu and Volker Zibat for experimental help.
Keywords: enzymes • flow biocatalysis • immobilization •
microreactors • stereoselective reactions
[1]
[2]
a) A. J. Straathof, Chem Rev 2014, 114, 1871-1908; b) R. A. Sheldon,
J. M. Woodley, Chem Rev 2017.
a) A. H. Chen, P. A. Silver, Trends Cell Biol 2012, 22, 662-670; b) I.
Wheeldon, S. D. Minteer, S. Banta, S. C. Barton, P. Atanassov, M.
Sigman, Nat Chem 2016, 8, 299-309; c) A. Kuchler, M. Yoshimoto, S.
Luginbuhl, F. Mavelli, P. Walde, Nat. Nanotechnol. 2016, 11, 409-420;
d) Z. Chen, A. P. Zeng, Curr. Opin. Biotechnol. 2016, 42, 198-205; e)
M. B. Quin, K. K. Wallin, G. Zhang, C. Schmidt-Dannert, Org Biomol
Chem 2017; f) S. P. France, L. J. Hepworth, N. J. Turner, S. L. Flitsch,
ACS Catal. 2017, 7, 710-724; g) K. S. Rabe, J. Muller, M. Skoupi, C. M.
Niemeyer, Angew Chem Int Ed Engl 2017, 56, 13574-13589.
a) S. V. Ley, D. E. Fitzpatrick, R. J. Ingham, R. M. Myers, Angew Chem
Int Ed Engl 2015, 54, 3449-3464; b) J. Li, S. G. Ballmer, E. P. Gillis, S.
Fujii, M. J. Schmidt, A. M. Palazzolo, J. W. Lehmann, G. F. Morehouse,
M. D. Burke, Science 2015, 347, 1221-1226; c) A. Adamo, R. L.
Beingessner, M. Behnam, J. Chen, T. F. Jamison, K. F. Jensen, J. C.
Monbaliu, A. S. Myerson, E. M. Revalor, D. R. Snead, T. Stelzer, N.
Weeranoppanant, S. Y. Wong, P. Zhang, Science 2016, 352, 61-67; d)
M. B. Plutschack, B. Pieber, K. Gilmore, P. H. Seeberger, Chem. Rev.
2017, 117, 11796-11893.
hydrogels hold
applications.
a
large potential for real-life laboratory
In conclusion, we established
a
novel class of self-
assembled all-enzyme hydrogels that are convenient to prepare
and readily mounted in fluidic microreactors. Conventional
(multi)enzyme processes require carrier materials, such as
beads or membranes, which inevitably ‘dilute’ the specific
activity of a given device and, thus, lead to lower STYs than
those available with all-enzyme systems.[1b, 17] Our approach is
based on recombinant protein technology, thereby enabling the
‘green’ sustainable production of biocatalytic devices with high
catalyst and volume productivity, high stability and low
production costs owing to the exclusion of additional expensive
carrier materials that require additional efforts for production and
disposal. The ultimately high concentrations of the biocatalyst in
our hydrogels are comparably only to the so-called “cross-linked
enzyme aggregates” (CLEA) that can be produced from two or
[3]
[4]
a) S. Matosevic, N. Szita, F. Baganz, J. Chem. Technol. Biotechnol.
2011, 86, 325-334; b) R. Wohlgemuth, I. Plazl, P. Znidarsic-Plazl, K. V.
Gernaey, J. M. Woodley, Trends Biotechnol 2015, 33, 302-314; c) L.
Tamborini, P. Fernandes, F. Paradisi, F. Molinari, Trends Biotechnol
2017; d) T. Peschke, M. Skoupi, T. Burgahn, S. Gallus, I. Ahmed, K. S.
Rabe, C. M. Niemeyer, ACS Catalysis 2017, 7, 7866-7872; e) J. Britton,
R. P. Dyer, S. Majumdar, C. L. Raston, G. A. Weiss, Angew Chem Int
Ed Engl 2017, 56, 2296-2301; f) J. Britton, S. Majumdar, G. A. Weiss,
Chem. Soc. Rev. 2018; g) M. L. Contente, F. Paradisi, Nat. Catal. 2018,
1, 452-459.
more different proteins in
a
non-directional fashion by
glutaraldehyde mediated unselective cross-linking[18] or by
exploitation of metal coordination interactions.[19] These
approaches, however, are limited in terms of control over
enzyme stoichiometry, potentially adverse effects of the
chemical crosslinking on the enzyme activity, or sensitivity to
environmental conditions (e.g., pH and ion-strength of reaction
media).
[5]
[6]
K. Buchholz, V. Kasche, U. T. Bornscheuer, Biocatalysts and Enzyme
Technology - 2nd Edition, Wiley-Blackwell, Weinheim, 2012.
Since the industrial implementation of enzymatic flow
processes is difficult when expensive cofactors (e.g., NADPH)
need to be supplemented continuously,[20] our approach should
also be relevant for other important biocatalysts, such as P450
P. Jonkheijm, D. Weinrich, H. Schroeder, C. M. Niemeyer, H.
Waldmann, Angew. Chem. Int. Ed. ) 2008, 47, 9618-9647.
This article is protected by copyright. All rights reserved.